The goal of this program is to train 6 pre-doctoral PhD candidates and 12 PhD and MD post doctoral fellows per year in the research disciplines of greatest importance for identifying and solving the problems of lung health maintenance and disease. Since the last submission, our program has grown to 40 faculty and evolved permitting us to re-organize our scientific focus groups (SFGs) to specifically address the strategic areas of importance defined by NHLBI. We offer training in: 1. Development and Regenerative Medicine (including gene therapy and matrix biology);2. Immunology and Inflammation (including innate immunity, cytokine biology, vaccine development and emerging airborne infectious diseases) and;3. Population Sciences (including Genetics, Genomics, Epidemiology, and Bioinformatics /Systems Biology). Each of these disciplines has a critical mass of experienced senior and junior faculty mentors which represent a broad range of expertise for trainees, such that every trainee gets the advantage of the group expertise in weekly meetings. Each group has laboratories that offer basic, translational and clinical science experiences, purposely integrated to provide a learning experience for every trainee. This continues our 34 year tradition of placing pre- doctoral students and post-doctoral PhD and MD fellows in integrated environments to provide a full spectrum of translational experiences. We will provide traditional laboratory based research opportunities for pre-doctoral students interested in studying lung sciences after completion of course work from either of 2 formal degree granting pathways Bioinformatics/Systems Biology or Molecular Medicine. For MD post-doctoral trainees we provide unique, integrated and customized post doctoral Masters degree programs in Statistics/ Epidemiology, Public Health, Bioinformatics and Clinical Investigation combined with traditional laboratory based experiences in laboratories within the three SFGs;and similar lab based experiences for PhD post-doctoral trainees. This award has supported over 75 doctoral students and over 140 MD and PhD post- doctoral fellows over the past 34 years in multiple disciplines related to lung diseases. Our graduates include many Chiefs of Pulmonary Medicine, 2 Chairs in Medicine, 3 Associate Deans and numerous Professors and national leaders in every field of Pulmonary Science with high profile funded research programs. The breadth and depth of the training portfolio we now offer is the most superior research experience in our 34 years and is specifically designed to address all the major areas of strategic interest of the Division of Lung Diseases of NHLBI.

Public Health Relevance

. The science of health and disease has become increasingly complex, requiring highly coordinated research efforts to ask and answer relevant questions and sophisticated environments to train the individuals who will make tomorrow's most important discoveries. This T32 program offers training for pre-doctoral students and post-doctoral fellows in the most advanced areas of lung science in an integrated fashion, concentrating on providing high quality mentorship in the scientific disciplines most likely to make advancements in diagnosis and treatment of lung diseases: Infection and Immunity;the Development of the lung and how it can be regenerated;and how to manage the barrage of data provided by epidemiology, genetic and genomic studies of lung diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007035-38
Application #
8494651
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Colombini-Hatch, Sandra
Project Start
1975-07-01
Project End
2016-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
38
Fiscal Year
2013
Total Cost
$1,052,020
Indirect Cost
$65,106
Name
Boston University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Barrios, Juliana; Patel, Kruti R; Aven, Linh et al. (2017) Early life allergen-induced mucus overproduction requires augmented neural stimulation of pulmonary neuroendocrine cell secretion. FASEB J 31:4117-4128
Stevenson, Elizabeth K; Mehter, Hashim M; Walkey, Allan J et al. (2017) Association between Do Not Resuscitate/Do Not Intubate Status and Resident Physician Decision-making. A National Survey. Ann Am Thorac Soc 14:536-542
Jiang, Zhiqiang; Knudsen, Nelson H; Wang, Gang et al. (2017) Genetic Control of Fatty Acid ?-Oxidation in Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol 56:738-748
Coleman, Fadie T; Blahna, Matthew T; Kamata, Hirofumi et al. (2017) Capacity of Pneumococci to Activate Macrophage Nuclear Factor ?B: Influence on Necroptosis and Pneumonia Severity. J Infect Dis 216:425-435
Moses, Elizabeth; Wang, Teresa; Corbett, Sean et al. (2017) Molecular Impact of Electronic Cigarette Aerosol Exposure in Human Bronchial Epithelium. Toxicol Sci 155:248-257
Patel, Kruti R; Bai, Yan; Trieu, Kenneth G et al. (2017) Targeting acetylcholine receptor M3 prevents the progression of airway hyperreactivity in a mouse model of childhood asthma. FASEB J 31:4335-4346
Konieczynska, Marlena D; Villa-Camacho, Juan C; Ghobril, Cynthia et al. (2017) A hydrogel sealant for the treatment of severe hepatic and aortic trauma with a dissolution feature for post-emergent care. Mater Horiz 4:222-227
Wasserman, Gregory A; Szymaniak, Aleksander D; Hinds, Anne C et al. (2017) Expression of Piwi protein MIWI2 defines a distinct population of multiciliated cells. J Clin Invest 127:3866-3876
Mehta, Anuj B; Cooke, Colin R; Douglas, Ivor S et al. (2017) Association of Early Do-Not-Resuscitate Orders with Unplanned Readmissions among Patients Hospitalized for Pneumonia. Ann Am Thorac Soc 14:103-109
Marquez, Hector A; Cardoso, Wellington V (2016) Vitamin A-retinoid signaling in pulmonary development and disease. Mol Cell Pediatr 3:28

Showing the most recent 10 out of 78 publications